Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Aas

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2015
Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristicsS Hofvind, Å Holen, T Aas, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2009
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor statusP E Lønning, H Helle, N K Duong, et al.
British Journal of Cancer|July 5, 2001
Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancerS I Helle, S Geisler, T Aas, et al.
Breast (Edinburgh, Scotland)|July 31, 2012
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancerK Krüger, I M Stefansson, K Collett, et al.
International Journal of Cancer|February 20, 1997
Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancerT Paulsen, T Aas, A L Børresen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcomeT Aas, S Geisler, T Paulsen, et al.
British Journal of Cancer|June 16, 2011
Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancerL A Akslen, O Straume, S Geisler, et al.
Nature Medicine|July 1, 1996
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsT Aas, A L Børresen, S Geisler, et al.
British Journal of Cancer|January 1, 1997
Absence of p21 expression is associated with abnormal p53 in human breast carcinomasP A Ellis, P E Lonning, A Borresen-Dale, et al.
Cancer Research|April 6, 2001
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancerS Geisler, P E Lønning, T Aas, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2015
Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristicsS Hofvind, Å Holen, T Aas, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2009
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor statusP E Lønning, H Helle, N K Duong, et al.
British Journal of Cancer|July 5, 2001
Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancerS I Helle, S Geisler, T Aas, et al.
Breast (Edinburgh, Scotland)|July 31, 2012
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancerK Krüger, I M Stefansson, K Collett, et al.
International Journal of Cancer|February 20, 1997
Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancerT Paulsen, T Aas, A L Børresen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcomeT Aas, S Geisler, T Paulsen, et al.
British Journal of Cancer|June 16, 2011
Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancerL A Akslen, O Straume, S Geisler, et al.
Nature Medicine|July 1, 1996
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsT Aas, A L Børresen, S Geisler, et al.
British Journal of Cancer|January 1, 1997
Absence of p21 expression is associated with abnormal p53 in human breast carcinomasP A Ellis, P E Lonning, A Borresen-Dale, et al.
Cancer Research|April 6, 2001
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancerS Geisler, P E Lønning, T Aas, et al.
Pageof 4